SuperworthANI Pharmaceuticals shares outstanding ANIP
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 21.9M
- On a year earlier
- +7.9%
- more shares
ANI Pharmaceuticals had 21.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 7.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 22.2M | +14% |
| FY2024 | 19.4M | +1% |
| FY2023 | 19.3M | +18% |
| FY2022 | 16.3M | +15% |
| FY2021 | 14.2M | +18% |
| FY2020 | 12M | +1% |
| FY2019 | 11.9M | +1% |
| FY2018 | 11.8M | +2% |
| FY2017 | 11.6M | +0% |
| FY2016 | 11.5M | −0% |
| FY2015 | 11.6M | −1% |
| FY2014 | 11.6M | +22% |
| FY2013 | 9.5M | +133% |
| FY2012 | 4.1M | +34% |
| FY2011 | 3.1M | +54% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 21.9M | +8% | |
| Q1 FY26 | 21.5M | +7% | |
| Q4 FY25 | 22.2M | +14% | |
| Q3 FY25 | 21.1M | +9% | |
| Q2 FY25 | 20.3M | +5% | |
| Q1 FY25 | 20M | +3% | |
| Q4 FY24 | 19.4M | +1% | |
| Q3 FY24 | 19.4M | +1% | |
| Q2 FY24 | 19.3M | +8% | |
| Q1 FY24 | 19.4M | +17% | |
| Q4 FY23 | 19.3M | +18% | |
| Q3 FY23 | 19.1M | +17% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ANI Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.